NEW YORK, Nov. 09, 2018 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP announces that class action lawsuits have
commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead
plaintiff have until the deadlines listed to petition the court and further details about the cases can be found at the links
provided. There is no cost or obligation to you.
AbbVie Inc. (NYSE: ABBV)
Class Period: October 25, 2013 - September 18, 2018
Lead Plaintiff Deadline: November 20, 2018
Join the action: https://www.zlk.com/pslra-1/abbvie-inc-loss-form?wire=3
Allegations: AbbVie Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) AbbVie’s
strategy to increase the sales growth of its blockbuster drug, HUMIRA, relied in part upon illegal kickbacks and unlawful sales and
marketing tactics; (2) such practices would foreseeably lead to heightened scrutiny by State governments and agencies; and (3) as a
result, Defendants’ public statements were materially false and misleading at all relevant times.
To learn more about the AbbVie Inc. class action contact jlevi@levikorsinsky.com.
Honeywell International Inc. (NYSE: HON)
Class Period: February 9, 2018 - October 19, 2018
Lead Plaintiff Deadline: December 31, 2018
Join the action: https://www.zlk.com/pslra-1/honeywell-international-inc-loss-form?wire=3
Allegations: During the class period, Honeywell International Inc. made materially false and/or misleading statements and/or
failed to disclose that: (1) Honeywell’s Bendix Friction Materials ("Bendix") asbestos-related liability was greater than initially
reported; (2) the Company maintained improper accounting practices in connection with its Bendix asbestos-related liability; and
(3) as a result, Honeywell’s public statements were materially false and misleading at all relevant times. Honeywell
previously owned Bendix, which used asbestos in its brake- and clutch-pad products until 2001; the Company sold Bendix in 2014.
On August 23, 2018, Honeywell announced it had "revised its method for reasonably estimating its liability for unasserted Bendix
asbestos-related claims by considering the epidemiological projections through 2059 of future incidence of Bendix asbestos-related
disease. Using this method, the Company’s Bendix asbestos-related liability is estimated to be $1,693 million as of June 30, 2018.
This is $1,083 million higher than the Company’s prior estimation which applied a five-year horizon when estimating the liability
for unasserted Bendix asbestos-related claims. The Bendix asbestos-related insurance assets are estimated to be $187 million as of
June 30, 2018, which is $65 million higher than the Company’s prior estimate."
To learn more about the Honeywell International Inc. class action contact jlevi@levikorsinsky.com.
Dycom Industries, Inc. (NYSE: DY)
Class Period: November 20, 2017 - August 10, 2018
Lead Plaintiff Deadline: December 24, 2018
Join the action: https://www.zlk.com/pslra-1/dycom-industries-inc-loss-form?wire=3
Allegations: Dycom Industries, Inc. made materially false and/or misleading statements throughout the class period and/or failed
to disclose that: (i) Dycom’s large projects were highly dependent on permitting and tactical considerations, (ii) Dycom was facing
great uncertainties related to permitting issues; (iii) said uncertainties would expose Dycom to near-term margin pressure and
absorption issues, and (iv) as a result of the foregoing, Defendants’ statements about Dycom’s business, operations, and prospects,
were false and misleading and/or lacked a reasonable basis.
To learn more about the Dycom Industries, Inc. class action contact jlevi@levikorsinsky.com.
You have until the lead plaintiff deadlines to request the court appoint you as lead plaintiff. Your ability to share in any
recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys
have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of
dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com
